| NORFLOXACIN VS CEFTRIAXONE IN THE PROPHYLAXIS OF INFECTIONS IN PATIENTS WITH ADVANCED CIRRHOSIS AND HEMORRHAGE |
 |
| Oral norfloxacin is the standard of
therapy in the prophylaxis of bacterial infections in cirrhotic
patients with gastrointestinal hemorrhage. However, during
the last years, the epidemiology of bacterial infections in
cirrhosis has changed, with a hi |
|
| A RANDOMISED TRIAL TO COMPARE THE PHARMACOKINETIC, PHARMACODYNAMIC, AND ANTIVIRAL EFFECTS OF PEGINTERFERON ALFA-2B |
|
| Hepatitis C virus (HCV) is the leading cause of liver
transplantation in the US and Europe and is associated
with an increased risk of hepatocellular carcinoma [1,2].
Owing to the chronic nature of the disease, estimates
suggest that its healthcare bu |
|
|
| PATIENTS WITH ELEVATED LIVER ENZYMES ARE NOT AT HIGHER RISK |
|
| NAGA CHALASANI,* HISHAM ALJADHEY, ‡ JOE KESTERSON, § MICHAEL D. MURRAY, and
STEPHEN D. HALL Gastroenterology 2004; 126: 1287-1292. |
|
|
| CHRONIC HEPATITIS B: A CRITICAL APPRAISAL OF CURRENT APPROACHES TO THERAPY |
|
| ROBERT P. PERRILLO, ROBERT G. GISH, MARION PETERS, EMMET B. KEEFFE, ALFREDO ALBERTI, MARIA BUTI, W. GRAHAM E. COOKSLEY, MICHAEL W. FRIED, STEPHANOS J. HADZIYANNIS, YUN–FAN LIAW, NIKOLAI V. NAOUMOV, EUGENE R. SCHIFF, CHLOE L. THIO, NAOKY TSAI. |
|
|
| COFFEE AND TEA CONSUMPTION ARE ASSOCIATED WITH A LOWER INCIDENCE OF CHRONIC LIVER DISEASE IN THE UNITED STATES |
|
| CONSTANCE E. RUHL and JAMES E. EVERHART
Social and Scientific Systems, Inc, Silver Spring, Maryland, and National Institute of Diabetes and Digestive and Kidney Diseases,
National Institutes of Health, Department of Health and Human Services, Bethesda, |
|
|
| OUTCOME AND PROGNOSTIC MARKERS IN SEVERE DRUG - INDUCED LIVER DISEASE |
|
| Einar Bjornsson and Rolf Olsson. hepatology 2005; 42: 481 - 489. |
|
|
| SAMPLING VARIABILITY OF LIVER BIOPSY IN NON ALCOHOLIC FATTY LIVER DISEASE |
|
| VLAD RATZIU, FRÉDÉRIC CHARLOTTE, AGNÈS HEURTIER, SOPHIE GOMBERT, PHILIPPE GIRAL,
ERIC BRUCKERT, ANDRÉ GRIMALDI, FRÉDÉRIQUE CAPRON, and THIERRY POYNARD for the
LIDO Study Group Service d’Hépatogastroentérologie, Laboratoire d’Anatomie Pathologique |
|
|
| COFFEE CONSUMPTION REDUCES THE RISK OF HEPATOCELLULAR CARCINOMA: A CASE CONTROL STUDY. J HEPATOLOGY 2005:42; 528-534 |
|
| Background/Aims: The role of coffee in the development of hepatocellular carcinoma (HCC) is debated. The aim of
this study was to investigate the role of coffee in HCC, taking the main risk factors into account.
Methods: A hospital-based case-control st |
|
|
| THE EFFECT OF URSODEOXYCHOLIC ACID THERAPY ON THE NATURAL COURSE OF PRIMARY BILIARY CIRROHISIS |
|
| Corpechot CH, Cerrat F, Bahr A et al. Gastroenterology 2005 ;128 :297 – 303. |
|
|
| THE PREDICTIVE VALUE OF ADMISSION AND FOLLOW UP FACTOR V AND VII LEVELS IN PATIENTS WITH ACUTE HEPATITIS AND COAGULOPATHY. |
|
| Acute hepatic failure is often associated with a wide
spectrum of coagulation abnormalities, mainly due to
reduced hepatic production and increased peripheral
consumption of coagulation factors [1]. |
|
|
| RAPID DIAGNOSIS OF SPONTANEOUS BACTERIAL PERITONITIS BY USE OF REAGENT STRIP |
|
| We studied the use of reagent strips for diagnosis of spontaneous bacterial peritonitis (SBP)in cirrhotic patients with ascites. A reagent strip for leukocyte esterase designed for the
testing of urine with a colorimetric 5-grade scale (0 to 4) was used. |
|
|
| PEGINTERFERON ALFA-2B PLUS RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS C IN PREVIOUSLY UNTREATED PATIENTS INFECTED WITH HVC GENOTYPES 2 OR 3 |
|
| En pacientes infectados por los genotipos 2 y 3 del virus C comparados con los pacientes infectados con el genotipo 1, con relación al tratamiento antiviral se ha demostrado |
|
|
